Invention Grant
US08025906B2 Pharmaceutical composition comprising plant material or Trichilia sp. alone or in association with other plant extracts for the reversion/combat and/or prevention of ventricular fibrillation
有权
包含植物材料或Trichilia sp。 单独或与其他植物提取物相关联用于逆转/作战和/或预防心室颤动
- Patent Title: Pharmaceutical composition comprising plant material or Trichilia sp. alone or in association with other plant extracts for the reversion/combat and/or prevention of ventricular fibrillation
- Patent Title (中): 包含植物材料或Trichilia sp。 单独或与其他植物提取物相关联用于逆转/作战和/或预防心室颤动
-
Application No.: US12100834Application Date: 2008-04-10
-
Publication No.: US08025906B2Publication Date: 2011-09-27
- Inventor: Ney Osvaldo Silva Filho , Luc Edmond Leon Andre Raes , Carlos Eduardo De Carvalho , Irineu Tadeu Velasco , Vera Pontieri , Augusto Scalabrini Neto , Celia Ivete Fernandes
- Applicant: Ney Osvaldo Silva Filho , Luc Edmond Leon Andre Raes , Carlos Eduardo De Carvalho , Irineu Tadeu Velasco , Vera Pontieri , Augusto Scalabrini Neto , Celia Ivete Fernandes
- Applicant Address: BR Joinville-SC
- Assignee: Laboratorio Catarinense S/A
- Current Assignee: Laboratorio Catarinense S/A
- Current Assignee Address: BR Joinville-SC
- Agency: Alston & Bird LLP
- Priority: BR0302750 20030808
- Main IPC: A61K36/00
- IPC: A61K36/00 ; A61K36/906
Abstract:
The present invention relates to the use of a plant material of the species Trichilia sp., alone or in association with one or more of the following plants: Paullinia cupana (Sapindaceae), Croton moritibensis (Euphorbiaceae) and Zingiber officinale (Zingiberaceae) in the treatment, reversion, combat and/or prevention of ventricular fibrillation. A product particularly embraced by the present invention comprises the plant material of the species Trichilia sp., alone or in association with extracts from other plants. The invention also refers to the use of one or more fractions of plant extract from such plant material, particularly of Trichilia catigua A. Juss, and of one or more subfractions of said fractions in the treatment, combat, prevention and/or reversion of ventricular fibrillation.
Public/Granted literature
Information query
